Clinical Trial Update: Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a combination of temozolomide, memantine hydrochloride, mefloquine, and metformin hydrochloride in glioblastoma multiforme (gliosarco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Glucophage (metformin)
• Lariam (mefloquine hydrochloride)
• Namenda (memantine)
• Temodar (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: TERMINATED